Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple MyelomaJune 28, 2022Multiple MyelomaHematologic Malignancies
‘Extremely exciting’ study results guide MM treatment optionsJune 6, 2022Multiple MyelomaAMLMyelodysplastic SyndromeMixed TopicsHematologic MalignanciesOncology
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022Multiple MyelomaMixed TopicsOncology
Obesity increasing the risk for cancer: It’s complicatedMarch 31, 2022ObesityOncologyMultiple MyelomaBreast CancerLung CancerGenitourinary Cancer
FDA approves new CAR T-cell treatment for multiple myelomaMarch 1, 2022Multiple MyelomaHematologic MalignanciesCancerOncology
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022Diversity in MedicineOncologyMultiple MyelomaOncology
Isatuximab added to RVd boosts response in new myelomaDecember 13, 2021Multiple MyelomaHematologic Malignancies
FDA approves time-saving combo for r/r multiple myelomaDecember 2, 2021Multiple MyelomaHematologic MalignanciesOncologyCancer
Severe COVID two times higher for cancer patientsNovember 8, 2021Breast CancerCOVID-19 UpdatesOncologyGenitourinary CancerMultiple MyelomaLung Cancer
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Multiple MyelomaBreast CancerGenitourinary CancerLung CancerOncology
Cancer screening stopped by pandemic: Repercussions to come?April 8, 2021Lung CancerBreast CancerCOVID-19 UpdatesMixed TopicsGenitourinary CancerMultiple MyelomaOncology
Steroids can be stopped in some older multiple myeloma patientsApril 1, 2021Multiple MyelomaHematologic MalignanciesGeriatrics
First CAR T-cell therapy for multiple myeloma: AbecmaMarch 29, 2021Multiple MyelomaHematologic Malignancies
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Breast CancerGenitourinary CancerLung CancerMultiple MyelomaOncologyHealth Policy
